Salman M Azam, MD
Interventional Cardiology · Torrance
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
- Since medical school
- 21 years
- Wayne State University School of Medicine, 2005
Offices
4 locations · Torrance Memorial Medical Center · Cor Healthcare Medical Associates · Southern California Hospitalist Network Medical Group Inc · Torrance Health Association Inc
Hospitals listed: Providence Little Company of Mary Med Ctr Torrance · Providence Little Co of Mary Med Ctr San Pedro · Torrance Memorial Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Azam’s office to ask if they take your plan before you enroll.
California Medical Board record
Surgery centers they own
- Newport Bay Sugery Center, LLC dba Newport Bay Surgery CenterAmbulatory Surgery Center · Newport Beach, CA3.67% owner since 2013 · accredited by AAAHCAccreditation Renewed2 inspections · last 2025-07-28
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Providence Little Co of Mary Med Ctr San PedroSan Pedro, CAAcute Care Hospital · Voluntary non-profit - Private · No emergency departmentPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Providence Little Company of Mary Med Ctr TorranceTorrance, CAAcute Care Hospital · Voluntary non-profit - Church · No emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.472, Oct 2024 – Sep 2025
- Torrance Memorial Medical CenterTorrance, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Cedars Sinai Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 82% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.36 (1.11 to 1.61), Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 15.79 (10.51 to 21.07) · 1,494 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.21 (0.72 to 1.71) · 9,154 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.328, Oct 2024 – Sep 2025
See every measure and the patient survey for Providence Little Co of Mary Med Ctr San Pedro
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 6 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.08) · 260 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.45 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.3 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.2 · 86 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.8 · 115 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.2 · 46 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 844 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 1,991 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,930 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.21 (0.68 to 5.75) · 195 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.6 (0.89 to 4.31) · 181 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.82 (0 to 18.7) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.05 (0.78 to 9.31) · 47 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 53 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.35 (0 to 1.36) · 1,620 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.7 · 28 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.687 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 170 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -2.2 · 103 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5.6 · 126 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 182 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 25 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 52 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.3 to 17.3) · 120 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 56 cases | No different | Jan 2024 – Dec 2024 |
What patients said (414 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Providence Little Company of Mary Med Ctr Torrance
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 8 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.472 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.09 (0.11 to 2.07) · 1,022 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.59 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 129.31 (75.73 to 182.88) · 65 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 36 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 70 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.4 · 353 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 361 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 495 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 3,150 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 5,786 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.06 to 0.45) · 5,832 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.21 (2.1 to 6.32) · 1,135 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.81 (0.22 to 3.4) · 375 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.8 to 3.86) · 1,086 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.78 (2.28 to 15.28) · 389 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.58 (1.19 to 7.98) · 377 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2 (0.51 to 3.49) · 247 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 0.93) · 4,918 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 127 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.892 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.225 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.363 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 283 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 709 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 10.5 · 149 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7.9 · 428 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -13.8 · 369 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 551 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.7 · 59 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 168 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.8 (8.9 to 15.5) · 642 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 331 cases | No different | Jan 2024 – Dec 2024 |
What patients said (414 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for Torrance Memorial Medical Center
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 1 worse of 8 measures. Readmissions: 0 better, 8 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.36 (1.11 to 1.61) | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 15.79 (10.51 to 21.07) · 1,494 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.21 (0.72 to 1.71) · 9,154 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.328 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.72) · 2,154 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 171.72 (128.91 to 214.54) · 121 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.2 · 36 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8 · 136 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 176 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.8 · 766 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 806 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 608 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 7,587 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.28 (0.1 to 0.47) · 11,109 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.03 to 0.39) · 11,330 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.13 (2.41 to 5.85) · 2,964 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0.13 to 3.16) · 1,513 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.66 (1.3 to 4.01) · 2,802 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.24 (2.35 to 8.14) · 1,479 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.55 (0.11 to 2.98) · 650 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2 · 962 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.023 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.646 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.751 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.259 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.658 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.1 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 1,578 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 21.1 · 183 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1.5 · 900 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.9 · 800 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.1 · 1,223 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.3) · 26 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7 to 15) · 26 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 928 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12 · 65 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21 · 316 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.5 to 16.1) · 624 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 781 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,607 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$161,730
Medicare paid this office $161,730 for 897 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 236 | $28,204 | $73 |
| Long return visit (40+ min) | 89 | $14,546 | $109 |
| Replacement of aortic valve through the skin and femoral artery | 21 | $11,881 | $566 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 79 | $10,365 | $60 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 14 | $7,318 | $41 |
See all 27 services
| Return visit (30+ min) | 236 | $28,204 | $73 |
| Long return visit (40+ min) | 89 | $14,546 | $109 |
| Replacement of aortic valve through the skin and femoral artery | 21 | $11,881 | $566 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 79 | $10,365 | $60 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 14 | $7,318 | $41 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 17 | $7,063 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $6,986 | $127 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 17 | $6,312 | $43 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 106 | $6,211 | $56 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 22 | $5,698 | $259 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 67 | $3,718 | $55 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 436 | $3,129 | $6 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 17 | $2,991 | $41 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $2,900 | $97 |
| New patient visit (60+ min) | 19 | $2,757 | $145 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 14 | $2,459 | $176 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 11 | $1,816 | $165 |
| Ultrasound of heart with probe in esophagus, with report | 20 | $1,728 | $86 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 20 | $605 | $28 |
| Anticoagulant management of patient taking warfarin | 21 | $516 | $9 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 41 | $326 | $6 |
| Ultrasound of heart blood flow, valves and chambers | 17 | $247 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $191 | $17 |
| 3d radiographic procedure | 24 | $171 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $126 | $11 |
| 3d radiographic procedure | 12 | $93 | $8 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $50 | $3 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 15 | More than 39% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Replacement of aortic valve through the skin and femoral artery | 27 | 13 | 17 | 13 | 11 | 21 |
| Repair of mitral valve through the skin, initial prosthesis | – | 18 | 15 | 18 | 13 | – |
| Repair of left upper heart chamber with implant with review by radiologist | – | – | 11 | 13 | 17 | – |
| Repair of mitral valve through the skin, additional prosthesis | – | – | – | 12 | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
897 Original Medicare patients in 2024. Average age 78 · Under 65 6% · 85 and older 26% · Women 48% · Also on Medicaid 25% · Health risk score 2.20. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 52% · Heart failure 51% · Diabetes 48% · Chronic kidney disease 47% · Atrial fibrillation 45% · Depression 26% · COPD 21% · Stroke 19% · Cancer 18% · Dementia 16%.
The office billed $529,495, Medicare allowed $214,090 and paid $161,730; for 2,523 services of 64 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 897 | 2,523 | 78 | 2.20 | $529,495 | $161,730 |
| 2023 | 805 | 2,631 | 78 | 2.17 | $566,466 | $178,288 |
| 2022 | 924 | 2,664 | 78 | 2.20 | $579,709 | $187,042 |
| 2021 | 759 | 2,119 | 78 | 2.17 | $537,407 | $172,539 |
| 2020 | 940 | 2,006 | 78 | 2.48 | $477,685 | $146,859 |
| 2019 | 644 | 1,651 | 79 | 2.26 | $486,681 | $144,986 |
| 2018 | 530 | 1,543 | 79 | 2.36 | $435,235 | $131,072 |
| 2017 | 624 | 1,581 | 79 | 2.23 | $445,601 | $133,614 |
| 2016 | 649 | 1,568 | 78 | 2.35 | $405,816 | $121,377 |
| 2015 | 469 | 1,252 | 77 | 2.32 | $340,266 | $96,713 |
| 2014 | 372 | 1,150 | 77 | 2.09 | $301,703 | $91,130 |
| 2013 | 37 | 71 | 78 | 2.32 | $23,461 | $7,495 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 23 services
| Return visit (30+ min) | 242 | $32,253 | $72 |
| Repair of mitral valve through the skin, initial prosthesis | 13 | $18,797 | $1,446 |
| Long return visit (40+ min) | 91 | $15,781 | $114 |
| Repair of left upper heart chamber with implant with review by radiologist | 17 | $10,701 | $629 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 23 | $9,337 | $52 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 22 | $8,620 | $45 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 66 | $8,432 | $64 |
| Replacement of aortic valve through the skin and femoral artery | 11 | $6,639 | $604 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 23 | $6,560 | $285 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 21 | $6,527 | $42 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 112 | $6,265 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $4,616 | $125 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 67 | $3,564 | $52 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 16 | $3,524 | $41 |
| New patient visit (60+ min) | 20 | $2,926 | $146 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 365 | $2,661 | $6 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 13 | $1,976 | $33 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 13 | $815 | $58 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 95 | $672 | $6 |
| Ultrasound of heart, follow-up | 17 | $353 | $20 |
| 3d radiographic procedure | 46 | $326 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $195 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $128 | $12 |
2022: 24 services
| Return visit (30+ min) | 224 | $30,706 | $74 |
| Repair of mitral valve through the skin, initial prosthesis | 18 | $26,773 | $1,487 |
| Long return visit (40+ min) | 83 | $12,482 | $109 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 28 | $11,184 | $54 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 21 | $9,192 | $51 |
| Repair of left upper heart chamber with implant with review by radiologist | 13 | $8,333 | $641 |
| Replacement of aortic valve through the skin and femoral artery | 13 | $8,173 | $629 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 66 | $7,116 | $60 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 114 | $6,547 | $55 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 19 | $6,466 | $44 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 17 | $5,295 | $311 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,125 | $165 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 80 | $4,824 | $60 |
| New patient visit (60+ min) | 30 | $4,333 | $144 |
| Repair of mitral valve through the skin, additional prosthesis | 12 | $4,205 | $350 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 464 | $3,636 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $2,945 | $196 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $1,833 | $73 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 68 | $518 | $7 |
| Ultrasound of heart, follow-up | 14 | $321 | $21 |
| 3d radiographic procedure | 34 | $252 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $241 | $19 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 14 | $217 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $161 | $12 |
2021: 28 services
| Return visit (30+ min) | 221 | $31,595 | $77 |
| Repair of mitral valve through the skin, initial prosthesis | 15 | $22,866 | $1,524 |
| Long return visit (40+ min) | 78 | $12,290 | $122 |
| Replacement of aortic valve through the skin and femoral artery | 17 | $10,838 | $638 |
| Telephone medical discussion with physician, 21-30 minutes | 77 | $8,055 | $72 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $7,537 | $443 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 121 | $7,493 | $59 |
| Repair of left upper heart chamber with implant with review by radiologist | 11 | $7,376 | $671 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 25 | $6,846 | $274 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 63 | $5,778 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $5,505 | $157 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 29 | $4,322 | $35 |
| New patient visit (60+ min) | 27 | $4,258 | $158 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 65 | $3,953 | $61 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 15 | $3,674 | $59 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 299 | $2,387 | $7 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 13 | $2,082 | $45 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 11 | $1,747 | $159 |
| New patient visit (45+ min) | 17 | $1,598 | $94 |
| Ultrasound of heart with probe in esophagus, with report | 14 | $1,495 | $93 |
| Anticoagulant management of patient taking warfarin | 15 | $991 | $9 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 12 | $739 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 51 | $378 | $7 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 13 | $374 | $29 |
| Ultrasound of heart, follow-up | 12 | $327 | $22 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 11 | $205 | $19 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 11 | $197 | $18 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $43 | $3 |
2020: 25 services
| Repair of mitral valve through the skin, initial prosthesis | 18 | $27,788 | $1,544 |
| Return visit (30+ min) | 211 | $20,116 | $61 |
| Replacement of aortic valve through the skin and femoral artery | 13 | $7,902 | $608 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 24 | $7,466 | $311 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,276 | $173 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $7,075 | $393 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 63 | $7,045 | $61 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 104 | $6,781 | $62 |
| Long return visit (40+ min) | 63 | $6,339 | $82 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 95 | $6,034 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 485 | $4,212 | $7 |
| Ultrasound of heart with probe in esophagus, with report | 29 | $2,824 | $94 |
| Telephone medical discussion with physician, 21-30 minutes | 37 | $2,748 | $69 |
| Short return visit (20+ min) | 60 | $2,728 | $41 |
| New patient visit (60+ min) | 17 | $2,374 | $140 |
| New patient visit (45+ min) | 12 | $1,318 | $110 |
| Anticoagulant management of patient taking warfarin | 19 | $821 | $9 |
| Return visit (30+ min) | 11 | $752 | $68 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $489 | $44 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 15 | $290 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 41 | $278 | $6 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $208 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $194 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 16 | $103 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 28 | $81 | $3 |
2019: 22 services
| Return visit (30+ min) | 215 | $22,760 | $61 |
| Replacement of aortic valve through the skin and femoral artery | 27 | $19,096 | $707 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $10,630 | $171 |
| Long return visit (40+ min) | 68 | $10,574 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 93 | $9,803 | $61 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $6,977 | $436 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 86 | $5,424 | $59 |
| New patient visit (60+ min) | 30 | $4,112 | $137 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $3,983 | $306 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 53 | $3,462 | $63 |
| Ultrasound of heart with probe in esophagus, with report | 27 | $2,717 | $94 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $2,391 | $199 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,851 | $88 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 181 | $1,413 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 96 | $762 | $7 |
| Anticoagulant management of patient taking warfarin | 16 | $761 | $8 |
| Return visit (30+ min) | 11 | $736 | $67 |
| Short return visit (20+ min) | 15 | $650 | $43 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $299 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $228 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $153 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $55 | $3 |
2018: 15 services
| Return visit (30+ min) | 231 | $25,863 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 86 | $10,838 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $10,003 | $172 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 22 | $6,867 | $312 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 77 | $5,241 | $64 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 72 | $4,474 | $62 |
| Long return visit (40+ min) | 39 | $4,379 | $89 |
| Ultrasound of heart with probe in esophagus, with report | 27 | $3,088 | $94 |
| Anticoagulant management of patient taking warfarin | 16 | $1,374 | $10 |
| New patient visit (45+ min) | 13 | $1,315 | $101 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 83 | $691 | $7 |
| Return visit (30+ min) | 11 | $668 | $61 |
| Short return visit (20+ min) | 15 | $611 | $41 |
| Short return visit (20+ min) | 12 | $524 | $44 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 70 | $511 | $6 |
2017: 17 services
| Return visit (30+ min) | 223 | $24,890 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 61 | $10,987 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 81 | $10,445 | $61 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 25 | $7,239 | $290 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $6,972 | $387 |
| Long return visit (40+ min) | 30 | $4,536 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 84 | $4,528 | $53 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 75 | $4,119 | $52 |
| Ultrasound of heart with probe in esophagus, with report | 30 | $3,926 | $91 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 18 | $3,870 | $215 |
| New patient visit (45+ min) | 31 | $3,258 | $105 |
| Return visit (30+ min) | 23 | $1,916 | $62 |
| New patient visit (60+ min) | 12 | $1,720 | $143 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 181 | $1,496 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 107 | $822 | $7 |
| Short return visit (20+ min) | 15 | $650 | $41 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 21 | $348 | $7 |
2016: 16 services
| Return visit (30+ min) | 176 | $19,809 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 98 | $16,000 | $61 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $7,020 | $468 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,815 | $115 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 83 | $4,333 | $50 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $4,194 | $323 |
| Ultrasound of heart with probe in esophagus, with report | 28 | $3,923 | $103 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 17 | $3,874 | $228 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,777 | $172 |
| New patient visit (45+ min) | 38 | $3,671 | $97 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 53 | $2,666 | $48 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 285 | $2,369 | $7 |
| Short return visit (20+ min) | 15 | $780 | $39 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 76 | $576 | $7 |
| Short return visit (20+ min) | 13 | $528 | $41 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 21 | $258 | $6 |
2015: 16 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 123 | $18,000 | $60 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $9,251 | $441 |
| Return visit (30+ min) | 100 | $9,249 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $8,521 | $170 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 151 | $7,761 | $50 |
| Short return visit (20+ min) | 98 | $5,546 | $36 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 14 | $4,418 | $316 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 14 | $3,043 | $217 |
| New patient visit (45+ min) | 24 | $2,359 | $98 |
| Ultrasound of heart with probe in esophagus, with report | 22 | $2,353 | $98 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,381 | $106 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 11 | $1,300 | $118 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 136 | $1,088 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 18 | $301 | $17 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 20 | $287 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 18 | $196 | $11 |
2014: 15 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 90 | $22,496 | $60 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $7,311 | $457 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 125 | $6,706 | $52 |
| Short return visit (20+ min) | 98 | $5,913 | $42 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 17 | $5,618 | $330 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,678 | $167 |
| Return visit (30+ min) | 61 | $4,144 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,878 | $115 |
| New patient visit (45+ min) | 27 | $2,829 | $105 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $1,706 | $85 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 11 | $1,619 | $135 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 102 | $785 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 23 | $431 | $18 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $295 | $8 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 23 | $284 | $12 |
2013: 2 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,776 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,158 | $58 |
Medicaid work
$1,486 in 2024
Medicaid paid $1,486 for 214 billed services this clinician did in 2024, up to 45 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 214 | $1,486 |
| 2024 | 214 | 1 | 45 | $1,486 |
| 2023 | 252 | 2 | 56 | $2,507 |
| 2022 | 261 | 1 | 52 | $2,169 |
| 2021 | 173 | 1 | 64 | $1,319 |
| 2020 | 183 | 1 | 82 | $995 |
| 2019 | 26 | 1 | 13 | $225 |
| 2018 | 35 | 1 | 33 | $352 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 239 | $1,805 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 13 | $703 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 261 | $2,169 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 173 | $1,319 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 183 | $995 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 26 | $225 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 35 | $352 |
Drugs they prescribed that Part D paid
$654,372
Pharmacies billed $654,372 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,177) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
2,599 generic and fewer than 11 brand-name prescriptions · $654,372 in drug cost · 23 antibiotic prescriptions to 18 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 212 | $267,922 | $1,264 |
| Entresto | 90 | $114,576 | $1,273 |
| Xarelto | 93 | $108,228 | $1,164 |
| Jardiance | 40 | $52,342 | $1,309 |
| Repatha Sureclick | 39 | $36,753 | $942 |
See all 38 drugs
| Eliquis | 212 | $267,922 | $1,264 |
| Entresto | 90 | $114,576 | $1,273 |
| Xarelto | 93 | $108,228 | $1,164 |
| Jardiance | 40 | $52,342 | $1,309 |
| Repatha Sureclick | 39 | $36,753 | $942 |
| Brilinta | 19 | $15,189 | $799 |
| Icosapent Ethyl | 14 | $7,732 | $552 |
| Metoprolol | 290 | $4,696 | $16 |
| Carvedilol | 365 | $3,692 | $10 |
| Atorvastatin | 290 | $2,839 | $10 |
| Isosorbide Mononitrate Er | 151 | $2,831 | $19 |
| Clopidogrel | 167 | $1,885 | $11 |
| Furosemide | 242 | $1,437 | $6 |
| Losartan | 100 | $1,212 | $12 |
| Ranolazine Er | 11 | $1,193 | $108 |
| Potassium Chloride | 52 | $1,145 | $22 |
| Lisinopril | 117 | $1,085 | $9 |
| Diltiazem 24hr Er (Xr) | 20 | $965 | $48 |
| Diltiazem 24hr Er (Cd) | 35 | $961 | $27 |
| Digoxin | 27 | $815 | $30 |
| Rosuvastatin | 23 | $669 | $29 |
| Ezetimibe | 25 | $562 | $22 |
| Nitroglycerin | 32 | $561 | $18 |
| Amlodipine Besylate | 120 | $492 | $4 |
| Diltiazem 24hr Er | 15 | $474 | $32 |
| Metoprolol | 73 | $433 | $6 |
| Famotidine | 19 | $383 | $20 |
| Pravastatin | 28 | $381 | $14 |
| Amiodarone | 21 | $324 | $15 |
| Hydralazine | 18 | $323 | $18 |
| Benazepril | 20 | $278 | $14 |
| Spironolactone | 35 | $268 | $8 |
| Pantoprazole | 25 | $181 | $7 |
| Atenolol | 38 | $168 | $4 |
| Valsartan | 11 | $152 | $14 |
| Warfarin | 21 | $150 | $7 |
| Hydrochlorothiazide | 35 | $81 | $2 |
| Amoxicillin | 13 | $32 | $2 |
Year by year
| 2024 | 3,177 | 559 | 0% (0) | None | $654,372 |
| 2023 | 3,389 | 597 | 0% (0) | 15% | $613,259 |
| 2022 | 3,366 | 602 | 0% (0) | 15% | $634,084 |
| 2021 | 3,391 | 616 | 0% (0) | 16% | $530,677 |
| 2020 | 3,286 | 616 | None | 19% | $656,261 |
| 2019 | 3,091 | 546 | 0% (0) | 18% | $450,009 |
| 2018 | 2,943 | 507 | None | 17% | $293,767 |
| 2017 | 2,656 | 440 | None | 19% | $197,875 |
| 2016 | 2,778 | 373 | None | None | $167,034 |
| 2015 | 2,424 | 333 | None | None | $131,821 |
| 2014 | 1,539 | 259 | None | 21% | $70,769 |
| 2013 | 251 | 63 | 0% (0) | 20% | $15,137 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 41 drugs
| Eliquis | 181 | $215,558 | $1,191 |
| Xarelto | 101 | $127,583 | $1,263 |
| Entresto | 67 | $109,307 | $1,631 |
| Repatha Sureclick | 32 | $23,277 | $727 |
| Brilinta | 17 | $23,156 | $1,362 |
| Metoprolol | 300 | $8,768 | $29 |
| Carvedilol | 399 | $6,262 | $16 |
| Atorvastatin | 298 | $5,792 | $19 |
| Isosorbide Mononitrate Er | 173 | $5,175 | $30 |
| Clopidogrel | 206 | $3,860 | $19 |
| Furosemide | 255 | $2,388 | $9 |
| Lisinopril | 160 | $1,958 | $12 |
| Losartan | 113 | $1,939 | $17 |
| Ranolazine Er | 19 | $1,789 | $94 |
| Potassium Chloride | 56 | $1,693 | $30 |
| Bumetanide | 18 | $1,583 | $88 |
| Digoxin | 39 | $1,553 | $40 |
| Metolazone | 26 | $1,390 | $53 |
| Diltiazem 24hr Er (Cd) | 41 | $1,378 | $34 |
| Rosuvastatin | 26 | $1,352 | $52 |
| Amlodipine Besylate | 143 | $1,166 | $8 |
| Diltiazem 24hr Er (Xr) | 18 | $979 | $54 |
| Metoprolol | 95 | $851 | $9 |
| Nitroglycerin | 35 | $832 | $24 |
| Hydralazine | 19 | $728 | $38 |
| Pravastatin | 25 | $642 | $26 |
| Pantoprazole | 34 | $541 | $16 |
| Diltiazem 24hr Er | 15 | $517 | $34 |
| Spironolactone | 41 | $481 | $12 |
| Warfarin | 22 | $479 | $22 |
| Ezetimibe | 14 | $459 | $33 |
| Sotalol | 12 | $353 | $29 |
| Amiodarone | 11 | $316 | $29 |
| Torsemide | 14 | $298 | $21 |
| Benazepril | 17 | $270 | $16 |
| Simvastatin | 14 | $153 | $11 |
| Atenolol | 20 | $128 | $6 |
| Famotidine | 11 | $123 | $11 |
| Hydrochlorothiazide | 40 | $109 | $3 |
| Chlorhexidine Gluconate | 23 | $24 | $1 |
| Amoxicillin | 18 | $18 | $1 |
2022: 40 drugs
| Eliquis | 173 | $218,876 | $1,265 |
| Xarelto | 117 | $142,918 | $1,222 |
| Entresto | 68 | $115,222 | $1,694 |
| Brilinta | 33 | $39,693 | $1,203 |
| Repatha Sureclick | 23 | $16,692 | $726 |
| Metoprolol | 286 | $7,445 | $26 |
| Carvedilol | 428 | $6,501 | $15 |
| Atorvastatin | 335 | $5,432 | $16 |
| Clopidogrel | 245 | $4,627 | $19 |
| Isosorbide Mononitrate Er | 137 | $4,022 | $29 |
| Ranolazine Er | 17 | $2,685 | $158 |
| Lisinopril | 178 | $1,973 | $11 |
| Furosemide | 240 | $1,913 | $8 |
| Diltiazem 24hr Er (Cd) | 53 | $1,707 | $32 |
| Rosuvastatin | 25 | $1,702 | $68 |
| Potassium Chloride | 35 | $1,431 | $41 |
| Nifedipine Er | 15 | $1,237 | $82 |
| Losartan | 94 | $1,114 | $12 |
| Amlodipine Besylate | 119 | $935 | $8 |
| Bumetanide | 12 | $818 | $68 |
| Metoprolol | 102 | $781 | $8 |
| Digoxin | 21 | $775 | $37 |
| Diltiazem 24hr Er | 17 | $764 | $45 |
| Nitroglycerin | 16 | $618 | $39 |
| Sotalol | 14 | $465 | $33 |
| Metolazone | 13 | $462 | $36 |
| Amiodarone | 22 | $431 | $20 |
| Warfarin | 22 | $413 | $19 |
| Hydralazine | 14 | $378 | $27 |
| Pravastatin | 29 | $374 | $13 |
| Famotidine | 14 | $363 | $26 |
| Spironolactone | 34 | $285 | $8 |
| Torsemide | 11 | $275 | $25 |
| Pantoprazole | 16 | $246 | $15 |
| Hydrochlorothiazide | 39 | $245 | $6 |
| Atenolol | 18 | $221 | $12 |
| Chlorhexidine Gluconate | 77 | $193 | $3 |
| Benazepril | 13 | $159 | $12 |
| Simvastatin | 13 | $84 | $6 |
| Amoxicillin | 15 | $33 | $2 |
2021: 37 drugs
| Eliquis | 181 | $190,370 | $1,052 |
| Xarelto | 136 | $137,228 | $1,009 |
| Entresto | 58 | $80,158 | $1,382 |
| Brilinta | 36 | $27,546 | $765 |
| Livalo | 14 | $7,601 | $543 |
| Carvedilol | 437 | $6,516 | $15 |
| Metoprolol | 238 | $6,107 | $26 |
| Atorvastatin | 327 | $5,647 | $17 |
| Isosorbide Mononitrate Er | 161 | $5,285 | $33 |
| Diltiazem 24hr Er (Cd) | 74 | $4,054 | $55 |
| Clopidogrel | 239 | $3,161 | $13 |
| Ranolazine Er | 11 | $2,502 | $227 |
| Matzim La | 12 | $2,465 | $205 |
| Furosemide | 274 | $1,911 | $7 |
| Potassium Chloride | 38 | $1,764 | $46 |
| Lisinopril | 148 | $1,454 | $10 |
| Rosuvastatin | 17 | $1,376 | $81 |
| Nitroglycerin | 27 | $1,142 | $42 |
| Losartan | 84 | $1,096 | $13 |
| Nifedipine Er | 16 | $1,066 | $67 |
| Amlodipine Besylate | 116 | $1,006 | $9 |
| Metoprolol | 113 | $868 | $8 |
| Hydralazine | 20 | $854 | $43 |
| Pravastatin | 37 | $819 | $22 |
| Digoxin | 20 | $806 | $40 |
| Diltiazem 24hr Er | 15 | $790 | $53 |
| Amiodarone | 20 | $633 | $32 |
| Sotalol | 18 | $521 | $29 |
| Warfarin | 27 | $473 | $18 |
| Spironolactone | 23 | $361 | $16 |
| Famotidine | 11 | $302 | $27 |
| Pantoprazole | 19 | $285 | $15 |
| Torsemide | 11 | $227 | $21 |
| Hydrochlorothiazide | 32 | $223 | $7 |
| Simvastatin | 26 | $204 | $8 |
| Chlorhexidine Gluconate | 99 | $166 | $2 |
| Benazepril | 13 | $145 | $11 |
2020: 36 drugs
| Eliquis | 167 | $156,647 | $938 |
| Xarelto | 116 | $122,277 | $1,054 |
| Entresto | 66 | $70,775 | $1,072 |
| Brilinta | 33 | $19,683 | $596 |
| Pradaxa | 11 | $11,849 | $1,077 |
| Repatha Sureclick | 18 | $8,352 | $464 |
| Metoprolol | 209 | $7,546 | $36 |
| Atorvastatin | 296 | $6,528 | $22 |
| Carvedilol | 435 | $6,398 | $15 |
| Isosorbide Mononitrate Er | 152 | $4,959 | $33 |
| Livalo | 13 | $4,696 | $361 |
| Clopidogrel | 262 | $4,265 | $16 |
| Potassium Chloride | 44 | $2,578 | $59 |
| Diltiazem 24hr Er (Cd) | 47 | $2,268 | $48 |
| Rosuvastatin | 16 | $2,056 | $128 |
| Furosemide | 246 | $1,928 | $8 |
| Lisinopril | 149 | $1,656 | $11 |
| Losartan | 89 | $1,383 | $16 |
| Metoprolol | 138 | $1,349 | $10 |
| Losartan-Hydrochlorothiazide | 13 | $1,288 | $99 |
| Amlodipine Besylate | 133 | $1,132 | $9 |
| Nifedipine Er | 14 | $968 | $69 |
| Digoxin | 23 | $959 | $42 |
| Warfarin | 46 | $708 | $15 |
| Pravastatin | 27 | $598 | $22 |
| Nitroglycerin | 17 | $502 | $30 |
| Amiodarone | 11 | $412 | $37 |
| Pantoprazole | 21 | $402 | $19 |
| Ramipril | 14 | $365 | $26 |
| Hydrochlorothiazide | 42 | $362 | $9 |
| Simvastatin | 33 | $309 | $9 |
| Spironolactone | 18 | $271 | $15 |
| Enalapril Maleate | 16 | $247 | $15 |
| Benazepril | 24 | $228 | $10 |
| Atenolol | 14 | $192 | $14 |
| Chlorhexidine Gluconate | 73 | $159 | $2 |
2019: 37 drugs
| Xarelto | 121 | $125,522 | $1,037 |
| Eliquis | 120 | $119,627 | $997 |
| Entresto | 28 | $27,265 | $974 |
| Brilinta | 45 | $20,600 | $458 |
| Pradaxa | 18 | $12,660 | $703 |
| Atorvastatin | 293 | $7,980 | $27 |
| Metoprolol | 198 | $7,673 | $39 |
| Carvedilol | 420 | $6,711 | $16 |
| Livalo | 14 | $5,869 | $419 |
| Isosorbide Mononitrate Er | 137 | $4,834 | $35 |
| Clopidogrel | 280 | $4,401 | $16 |
| Diltiazem 24hr Er (Cd) | 40 | $4,278 | $107 |
| Lisinopril | 161 | $1,714 | $11 |
| Potassium Chloride | 34 | $1,679 | $49 |
| Furosemide | 199 | $1,522 | $8 |
| Rosuvastatin | 13 | $1,511 | $116 |
| Losartan | 84 | $1,444 | $17 |
| Amlodipine Besylate | 138 | $1,342 | $10 |
| Metoprolol | 138 | $1,062 | $8 |
| Warfarin | 53 | $815 | $15 |
| Digoxin | 15 | $750 | $50 |
| Amiodarone | 17 | $725 | $43 |
| Diltiazem 24hr Er | 15 | $690 | $46 |
| Nitroglycerin | 17 | $573 | $34 |
| Pantoprazole | 37 | $561 | $15 |
| Klor-Con 10 | 11 | $353 | $32 |
| Spironolactone | 17 | $332 | $20 |
| Pravastatin | 16 | $315 | $20 |
| Benazepril | 20 | $296 | $15 |
| Simvastatin | 27 | $272 | $10 |
| Hydrochlorothiazide | 47 | $268 | $6 |
| Atenolol | 21 | $263 | $13 |
| Hydralazine | 12 | $254 | $21 |
| Lovastatin | 11 | $179 | $16 |
| Losartan-Hydrochlorothiazide | 11 | $165 | $15 |
| Enalapril Maleate | 11 | $112 | $10 |
| Chlorhexidine Gluconate | 18 | $17 | $1 |
2018: 39 drugs
| Xarelto | 105 | $96,073 | $915 |
| Eliquis | 100 | $84,192 | $842 |
| Entresto | 12 | $12,341 | $1,028 |
| Ranexa | 22 | $10,511 | $478 |
| Pradaxa | 15 | $7,793 | $520 |
| Atorvastatin | 227 | $6,649 | $29 |
| Metoprolol | 144 | $6,585 | $46 |
| Carvedilol | 388 | $5,900 | $15 |
| Diltiazem 24hr Er (Cd) | 42 | $5,253 | $125 |
| Isosorbide Mononitrate Er | 109 | $3,808 | $35 |
| Clopidogrel | 225 | $3,269 | $15 |
| Rosuvastatin | 19 | $2,240 | $118 |
| Lisinopril | 168 | $1,713 | $10 |
| Losartan | 108 | $1,522 | $14 |
| Potassium Chloride | 38 | $1,484 | $39 |
| Furosemide | 225 | $1,419 | $6 |
| Metoprolol | 182 | $1,379 | $8 |
| Warfarin | 71 | $1,306 | $18 |
| Nitroglycerin | 24 | $1,236 | $52 |
| Amlodipine Besylate | 101 | $951 | $9 |
| Digoxin | 13 | $848 | $65 |
| Bumetanide | 16 | $815 | $51 |
| Digox | 13 | $716 | $55 |
| Spironolactone | 34 | $577 | $17 |
| Simvastatin | 40 | $472 | $12 |
| Pravastatin | 19 | $465 | $24 |
| Valsartan | 11 | $408 | $37 |
| Benazepril | 39 | $401 | $10 |
| Pantoprazole | 27 | $342 | $13 |
| Omeprazole | 13 | $301 | $23 |
| Atenolol | 31 | $295 | $10 |
| Hydrochlorothiazide | 48 | $260 | $5 |
| Enalapril Maleate | 13 | $223 | $17 |
| Losartan-Hydrochlorothiazide | 17 | $210 | $12 |
| Hydralazine | 11 | $172 | $16 |
| Clonidine | 14 | $144 | $10 |
| Propranolol | 12 | $118 | $10 |
| Ciprofloxacin | 14 | $85 | $6 |
| Chlorhexidine Gluconate | 26 | $18 | $1 |
2017: 39 drugs
| Xarelto | 68 | $55,327 | $814 |
| Eliquis | 53 | $37,505 | $708 |
| Brilinta | 32 | $20,909 | $653 |
| Pradaxa | 18 | $7,454 | $414 |
| Atorvastatin | 235 | $6,169 | $26 |
| Carvedilol | 449 | $5,999 | $13 |
| Ranexa | 11 | $4,597 | $418 |
| Metoprolol | 97 | $3,971 | $41 |
| Isosorbide Mononitrate Er | 120 | $3,783 | $32 |
| Clopidogrel | 163 | $3,365 | $21 |
| Rosuvastatin | 16 | $2,364 | $148 |
| Diltiazem 24hr Er | 36 | $2,076 | $58 |
| Lisinopril | 162 | $1,444 | $9 |
| Digoxin | 26 | $1,255 | $48 |
| Furosemide | 176 | $1,235 | $7 |
| Warfarin | 53 | $1,227 | $23 |
| Metoprolol | 147 | $1,186 | $8 |
| Losartan | 74 | $929 | $13 |
| Potassium Chloride | 29 | $898 | $31 |
| Fenofibrate | 14 | $871 | $62 |
| Nitroglycerin | 25 | $863 | $35 |
| Amlodipine Besylate | 85 | $857 | $10 |
| Valsartan | 11 | $674 | $61 |
| Bumetanide | 15 | $595 | $40 |
| Pantoprazole | 33 | $570 | $17 |
| Pravastatin | 15 | $511 | $34 |
| Simvastatin | 47 | $462 | $10 |
| Hydralazine | 23 | $428 | $19 |
| Spironolactone | 32 | $426 | $13 |
| Omeprazole | 12 | $324 | $27 |
| Atenolol | 33 | $295 | $9 |
| Enalapril Maleate | 11 | $257 | $23 |
| Torsemide | 13 | $244 | $19 |
| Hydrochlorothiazide | 30 | $150 | $5 |
| Clonidine | 19 | $143 | $8 |
| Losartan-Hydrochlorothiazide | 11 | $143 | $13 |
| Propranolol | 12 | $136 | $11 |
| Alprazolam | 14 | $50 | $4 |
| Chlorhexidine Gluconate | 11 | $11 | $1 |
2016: 35 drugs
| Xarelto | 80 | $43,247 | $541 |
| Eliquis | 58 | $28,111 | $485 |
| Effient | 22 | $13,479 | $613 |
| Brilinta | 21 | $12,894 | $614 |
| Pradaxa | 14 | $6,728 | $481 |
| Atorvastatin | 235 | $5,478 | $23 |
| Carvedilol | 476 | $4,311 | $9 |
| Metoprolol | 92 | $3,543 | $39 |
| Clopidogrel | 135 | $3,285 | $24 |
| Isosorbide Mononitrate Er | 134 | $2,997 | $22 |
| Digoxin | 28 | $1,467 | $52 |
| Lisinopril | 206 | $1,399 | $7 |
| Furosemide | 194 | $1,200 | $6 |
| Metoprolol | 175 | $1,179 | $7 |
| Bumetanide | 22 | $1,156 | $53 |
| Potassium Chloride | 40 | $1,081 | $27 |
| Diltiazem 24hr Er | 23 | $902 | $39 |
| Pravastatin | 26 | $827 | $32 |
| Warfarin | 43 | $809 | $19 |
| Midodrine | 12 | $787 | $66 |
| Amlodipine Besylate | 85 | $758 | $9 |
| Nitrostat | 23 | $751 | $33 |
| Losartan | 79 | $726 | $9 |
| Simvastatin | 49 | $533 | $11 |
| Hydralazine | 16 | $482 | $30 |
| Tamsulosin | 14 | $445 | $32 |
| Spironolactone | 31 | $379 | $12 |
| Diltiazem Er | 13 | $370 | $28 |
| Atenolol | 31 | $348 | $11 |
| Amiodarone | 28 | $320 | $11 |
| Enalapril Maleate | 15 | $315 | $21 |
| Pantoprazole | 16 | $311 | $19 |
| Hydrochlorothiazide | 41 | $230 | $6 |
| Losartan-Hydrochlorothiazide | 11 | $206 | $19 |
| Ramipril | 12 | $132 | $11 |
2015: 38 drugs
| Xarelto | 74 | $31,265 | $423 |
| Effient | 28 | $15,947 | $570 |
| Eliquis | 35 | $14,423 | $412 |
| Crestor | 24 | $10,646 | $444 |
| Atorvastatin | 202 | $4,083 | $20 |
| Advair Diskus | 13 | $3,928 | $302 |
| Carvedilol | 428 | $3,668 | $9 |
| Metoprolol | 73 | $2,861 | $39 |
| Clopidogrel | 113 | $2,083 | $18 |
| Digoxin | 18 | $1,332 | $74 |
| Isosorbide Mononitrate Er | 59 | $1,188 | $20 |
| Pravastatin | 42 | $1,163 | $28 |
| Metoprolol | 198 | $1,092 | $6 |
| Lisinopril | 158 | $967 | $6 |
| Bumetanide | 16 | $927 | $58 |
| Potassium Chloride | 36 | $690 | $19 |
| Furosemide | 166 | $676 | $4 |
| Warfarin | 41 | $674 | $16 |
| Digox | 13 | $586 | $45 |
| Amlodipine Besylate | 65 | $576 | $9 |
| Diltiazem 24hr Cd | 15 | $534 | $36 |
| Diltiazem 24hr Er | 16 | $516 | $32 |
| Losartan | 49 | $496 | $10 |
| Nitrostat | 15 | $366 | $24 |
| Atenolol | 26 | $354 | $14 |
| Hydralazine | 17 | $332 | $20 |
| Simvastatin | 41 | $329 | $8 |
| Felodipine Er | 12 | $288 | $24 |
| Diltiazem Er | 11 | $244 | $22 |
| Amiodarone | 23 | $238 | $10 |
| Benazepril | 25 | $214 | $9 |
| Losartan-Hydrochlorothiazide | 17 | $210 | $12 |
| Spironolactone | 35 | $202 | $6 |
| Lovastatin | 22 | $187 | $8 |
| Hydrochlorothiazide | 19 | $172 | $9 |
| Pantoprazole | 11 | $165 | $15 |
| Ramipril | 12 | $152 | $13 |
| Clonidine | 13 | $147 | $11 |
2014: 28 drugs
| Xarelto | 48 | $15,899 | $331 |
| Effient | 23 | $11,159 | $485 |
| Eliquis | 14 | $4,273 | $305 |
| Crestor | 19 | $3,927 | $207 |
| Atorvastatin | 167 | $3,821 | $23 |
| Carvedilol | 282 | $3,260 | $12 |
| Clopidogrel | 63 | $2,568 | $41 |
| Metoprolol | 45 | $1,968 | $44 |
| Metoprolol | 150 | $1,018 | $7 |
| Digox | 19 | $826 | $43 |
| Amlodipine Besylate | 51 | $767 | $15 |
| Digoxin | 13 | $647 | $50 |
| Lisinopril | 80 | $553 | $7 |
| Felodipine Er | 17 | $533 | $31 |
| Isosorbide Mononitrate Er | 39 | $458 | $12 |
| Atenolol | 37 | $397 | $11 |
| Furosemide | 96 | $357 | $4 |
| Losartan | 16 | $306 | $19 |
| Pravastatin | 17 | $251 | $15 |
| Simvastatin | 17 | $239 | $14 |
| Warfarin | 16 | $238 | $15 |
| Potassium Chloride | 11 | $231 | $21 |
| Chlorthalidone | 12 | $230 | $19 |
| Benazepril | 20 | $222 | $11 |
| Diltiazem 24hr Cd | 15 | $222 | $15 |
| Hydrochlorothiazide | 25 | $178 | $7 |
| Amiodarone | 12 | $157 | $13 |
| Spironolactone | 17 | $150 | $9 |
2013: 6 drugs
| Clopidogrel | 35 | $1,908 | $55 |
| Atorvastatin | 29 | $600 | $21 |
| Metoprolol | 16 | $448 | $28 |
| Carvedilol | 18 | $143 | $8 |
| Lisinopril | 17 | $106 | $6 |
| Furosemide | 17 | $85 | $5 |
Money from drug and device companies
$18,082 in 2025
| 2025 | 19 | 124 | $13,125 | $18,082 |
| 2024 | 16 | 124 | $32,500 | $37,244 |
| 2023 | 17 | 133 | $45,513 | $51,125 |
| 2022 | 7 | 66 | $35,438 | $36,500 |
| 2021 | 6 | 62 | $29,925 | $31,864 |
| 2020 | 8 | 20 | $5,350 | $5,834 |
| 2019 | 11 | 119 | $13,750 | $19,275 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $15,620 | 19 payments
|
| Boston Scientific | Avvigo Guidance System | $591 | 28 payments
|
| Medtronic | Micra | $451 | 24 payments
|
| Abbott Laboratories | Triclip | $413 | 10 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $209 | 9 payments
|
| Novartis Pharmaceuticals | Leqvio | $136 | 6 payments
|
See all 122 published payments
| Edwards Lifesciences | Consulting · 2025-12-31 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $10,000 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-12-30 | Lifevest | $30 |
| Abbott Laboratories | Meals · 2025-12-30 | Amplatzer Amulet | $6 |
| Novartis Pharmaceuticals | Meals · 2025-12-17 | Leqvio | $22 |
| Esperion Therapeutics | Meals · 2025-12-14 | Nexletol | $20 |
| Scpharmaceuticals | Meals · 2025-12-10 | Furoscix | $23 |
| Edwards Lifesciences | Meals · 2025-12-05 | None | $177 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-21 | Eliquis | $26 |
| Boston Scientific | Meals · 2025-11-19 | Avvigo Guidance System | $27 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-11-14 | Jardiance | $29 |
| Esperion Therapeutics | Meals · 2025-11-10 | Nexletol | $17 |
| Medtronic | Meals · 2025-11-03 | Micra | $33 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-11-03 | Jardiance | $26 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-10-27 | Lifevest | $26 |
| Boston Scientific | Meals · 2025-10-24 | Avvigo Guidance System | $19 |
| Medtronic | Meals · 2025-10-23 | Micra | $5 |
| Kestra Medical Technology Services | Meals · 2025-10-23 | Assure Wcd | $17 |
| Medtronic | Meals · 2025-10-09 | Micra | $70 |
| Medtronic | Meals · 2025-10-08 | Micra | $14 |
| Heartflow | Meals · 2025-10-08 | Ffrct | $28 |
| Medtronic | Meals · 2025-10-02 | Micra | $4 |
| Medtronic | Meals · 2025-10-02 | Micra | $34 |
| Amgen | Meals · 2025-10-01 | Repatha | $24 |
| Boston Scientific | Meals · 2025-09-23 | Rotapro | $20 |
| BridgeBio Pharma | Meals · 2025-09-23 | Attruby | $43 |
| BridgeBio Pharma | Meals · 2025-09-20 | Attruby | $30 |
| Medtronic | Meals · 2025-09-18 | Micra | $3 |
| Inspire Medical Systems | Meals · 2025-09-10 | Inspire | $27 |
| Medtronic | Meals · 2025-09-03 | Micra | $31 |
| Medtronic | Meals · 2025-09-03 | Micra | $6 |
| Boston Scientific | Meals · 2025-08-28 | General - Balloon Catheters | $19 |
| Edwards Lifesciences | Meals · 2025-08-21 | Evoque | $126 |
| Novartis Pharmaceuticals | Meals · 2025-08-20 | Leqvio | $26 |
| Novartis Pharmaceuticals | Meals · 2025-08-20 | Leqvio | $26 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-08-18 | Lifevest | $23 |
| Medtronic | Meals · 2025-08-14 | Micra | $4 |
| Medtronic | Meals · 2025-08-08 | Micra | $28 |
| Boston Scientific | Meals · 2025-08-05 | Synergy | $21 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-07-31 | Lifevest | $20 |
| Boston Scientific | Meals · 2025-07-31 | Rotapro | $71 |
| Boston Scientific | Meals · 2025-07-30 | Avvigo Guidance System | $16 |
| Merck Sharp & Dohme | Meals · 2025-07-30 | Verquvo | $26 |
| Medtronic | Meals · 2025-07-29 | Micra | $33 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-07-23 | Jardiance | $19 |
| Edwards Lifesciences | Meals · 2025-07-22 | Sapien 3 Ultra Resilia | $29 |
| Boston Scientific | Meals · 2025-07-21 | Wolverine Coronary Cutting Balloon | $13 |
| Kestra Medical Technology Services | Meals · 2025-07-10 | Assure Wcd | $14 |
| Boston Scientific | Meals · 2025-07-02 | Comet | $20 |
| BridgeBio Pharma | Meals · 2025-07-01 | Attruby | $29 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-06-30 | Lifevest | $30 |
| Medtronic | Meals · 2025-06-27 | Micra | $3 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-06-26 | Lifevest | $27 |
| Boston Scientific | Meals · 2025-06-25 | Comet | $17 |
| Abbott Laboratories | Meals · 2025-06-20 | Amplatzer Amulet | $25 |
| Boston Scientific | Meals · 2025-06-11 | Avvigo Guidance System | $22 |
| Boston Scientific | Meals · 2025-06-04 | General - Atherectomy | $20 |
| Medtronic | Meals · 2025-06-04 | Micra | $7 |
| Merck Sharp & Dohme | Meals · 2025-06-04 | Verquvo | $23 |
| Abbott Laboratories | Meals · 2025-06-04 | Navitor | $9 |
| Scpharmaceuticals | Meals · 2025-06-02 | Furoscix | $20 |
| Boston Scientific | Meals · 2025-05-27 | Avvigo Guidance System | $20 |
| Boston Scientific | Meals · 2025-05-16 | Permanent Sled Bag | $18 |
| Medtronic | Meals · 2025-05-14 | Epsila Ev | $13 |
| Boston Scientific | Meals · 2025-05-11 | Avvigo Guidance System | $21 |
| Boston Scientific | Meals · 2025-05-09 | Avvigo Guidance System | $6 |
| Edwards Lifesciences | Meals · 2025-05-09 | Sapien 3 Ultra Resilia | $85 |
| Edwards Lifesciences | Meals · 2025-05-09 | Sapien 3 Ultra Resilia | $63 |
| Edwards Lifesciences | Travel · 2025-05-09 | Sapien 3 Ultra Resilia | $74 |
| Edwards Lifesciences | Meals · 2025-05-09 | Sapien 3 Ultra Resilia | $38 |
| Edwards Lifesciences | Travel · 2025-05-09 | Sapien 3 Ultra Resilia | $182 |
| Edwards Lifesciences | Meals · 2025-05-08 | Sapien 3 Ultra Resilia | $160 |
| Edwards Lifesciences | Meals · 2025-05-08 | Sapien 3 Ultra Resilia | $283 |
| Edwards Lifesciences | Meals · 2025-05-08 | Sapien 3 Ultra Resilia | $59 |
| Edwards Lifesciences | Travel · 2025-05-08 | Sapien 3 Ultra Resilia | $393 |
| Edwards Lifesciences | Travel · 2025-05-08 | Sapien 3 Ultra Resilia | $87 |
| Edwards Lifesciences | Travel · 2025-05-07 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $141 |
| Boston Scientific | Meals · 2025-05-01 | Avvigo Guidance System | $18 |
| Abbott Laboratories | Travel · 2025-04-30 | Triclip | $36 |
| Abbott Laboratories | Travel · 2025-04-30 | Triclip | $9 |
| Pfizer | Meals · 2025-04-29 | Vyndaqel | $18 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-04-28 | Lifevest | $1 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-04-28 | Jardiance | $27 |
| Boston Scientific | Meals · 2025-04-23 | Avvigo Guidance System | $18 |
| Medtronic | Meals · 2025-04-21 | Micra | $6 |
| Merck Sharp & Dohme | Meals · 2025-04-16 | Verquvo | $22 |
| Boston Scientific | Meals · 2025-04-15 | Avvigo Guidance System | $22 |
| Medtronic | Meals · 2025-04-14 | Micra | $30 |
| Medtronic | Meals · 2025-04-09 | Micra | $28 |
| Boston Scientific | Meals · 2025-04-04 | Synergy | $24 |
| Medtronic | Meals · 2025-04-01 | Epsila Ev | $30 |
| Boston Scientific | Meals · 2025-03-28 | Encore 26 | $19 |
| Medtronic | Meals · 2025-03-27 | Micra | $23 |
| Edwards Lifesciences | Travel · 2025-03-24 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $497 |
| Novartis Pharmaceuticals | Meals · 2025-03-21 | Leqvio | $14 |
| Boston Scientific | Meals · 2025-03-19 | General - Balloon Catheters | $18 |
| Boston Scientific | Meals · 2025-03-13 | Avvigo Guidance System | $21 |
| Pfizer | Meals · 2025-03-07 | Vyndaqel | $18 |
| Medtronic | Meals · 2025-03-04 | Micra | $9 |
| Scpharmaceuticals | Meals · 2025-03-03 | Furoscix | $27 |
| Abbott Laboratories | Meals · 2025-02-28 | Triclip | $65 |
| Abbott Laboratories | Meals · 2025-02-28 | Triclip | $77 |
| Abbott Laboratories | Meals · 2025-02-28 | Triclip | $127 |
| Abbott Laboratories | Meals · 2025-02-28 | Triclip | $45 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-02-24 | Lifevest | $28 |
| Medtronic | Meals · 2025-02-20 | Micra | $4 |
| AltaThera Pharmaceuticals | Meals · 2025-02-19 | Sotalol Hydrochloride | $30 |
| Medtronic | Meals · 2025-02-19 | Micra | $13 |
| Edwards Lifesciences | Consulting · 2025-02-18 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $3,125 |
| Edwards Lifesciences | Travel · 2025-02-18 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $64 |
| Medtronic | Meals · 2025-02-14 | Pulseselect | $23 |
| Boston Scientific | Meals · 2025-02-13 | Avvigo Guidance System | $16 |
| Abiomed | Meals · 2025-02-11 | None | $60 |
| Abbott Laboratories | Meals · 2025-01-31 | Triclip | $16 |
| Edwards Lifesciences | Meals · 2025-01-28 | Sapien 3 Ultra Resilia | $36 |
| Boston Scientific | Meals · 2025-01-24 | Watchdog | $20 |
| Pfizer | Meals · 2025-01-23 | Vyndaqel | $18 |
| Boston Scientific | Meals · 2025-01-16 | Avvigo Guidance System | $22 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-01-13 | Lifevest | $25 |
| Novartis Pharmaceuticals | Meals · 2025-01-10 | Leqvio | $23 |
| Boston Scientific | Meals · 2025-01-09 | Watchman Flx | $23 |
| Boston Scientific | Meals · 2025-01-06 | Avvigo Guidance System | $20 |
| Novartis Pharmaceuticals | Meals · 2025-01-06 | Leqvio | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $37,244
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $35,437 | 49 payments
|
| Abbott Laboratories | Mitraclip | $525 | 10 payments
|
| Boston Scientific | Avvigo Guidance System | $365 | 22 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $205 | 10 payments
|
| Pfizer | Vyndaqel | $119 | 6 payments
|
| Novartis Pharmaceuticals | Leqvio | $115 | 5 payments
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $96 | 5 payments
|
| Janssen Pharmaceuticals | Xarelto | $93 | 4 payments
|
| Medtronic | Micra | $70 | 3 payments
|
| Scpharmaceuticals | Furoscix | $68 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $46 | 2 payments
|
| iRhythm Technologies | Zio Monitor | $36 | 1 payment
|
| Alnylam Pharmaceuticals | Amvuttra | $25 | 1 payment
|
| Amgen | Repatha | $17 | 1 payment
|
| Kestra Medical Technology Services | Assure Wcd | $14 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | None | $13 | 1 payment
|
2023: $51,125
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $49,885 | 87 payments
|
| Abbott Laboratories | Mitraclip | $388 | 15 payments
|
| Medtronic | Micra | $188 | 6 payments
|
| Abiomed | Impella | $148 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $106 | 5 payments
|
| Actelion Pharmaceuticals US | Opsumit | $54 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $48 | 2 payments
|
| Novartis Pharmaceuticals | Leqvio | $45 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $45 | 2 payments
|
| Boston Scientific | Watchman Flx | $43 | 2 payments
|
| Kiniksa Pharmaceuticals | Arcalyst | $39 | 2 payments
|
| Pfizer | Vyndaqel | $39 | 2 payments
|
| Amgen | Repatha | $27 | 1 payment
|
| GE HealthCare | None | $23 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $18 | 1 payment
|
| Novo Nordisk | Ozempic | $17 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $14 | 1 payment
|
2022: $36,500
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $35,661 | 27 payments
|
| Medtronic | Micra | $362 | 18 payments
|
| Philips Electronics North America | (5044) Mcot | $200 | 2 payments
|
| Abbott Laboratories | Amplatzer Piccolo | $180 | 13 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $51 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $32 | 2 payments
|
| Abiomed | Impella | $14 | 1 payment
|
2021: $31,864
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $31,485 | 43 payments
|
| Medtronic | Micra | $199 | 8 payments
|
| Pfizer | Eliquis | $122 | 8 payments
|
| Boston Scientific | Watchman | $24 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $18 | 1 payment
|
| Novo Nordisk | Ozempic | $17 | 1 payment
|
2020: $5,834
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve | $5,446 | 6 payments
|
| Abbott Laboratories | Optis Coronary Imaging System | $174 | 4 payments
|
| Boston Scientific | Watchman | $75 | 3 payments
|
| Pfizer | Vyndaqel | $44 | 2 payments
|
| Medtronic Vascular | Micra | $32 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $24 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $21 | 1 payment
|
| Alnylam Pharmaceuticals | Onpattro | $18 | 1 payment
|
2019: $19,275
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve | $16,197 | 38 payments
|
| Boston Scientific | General Therapies | $1,897 | 11 payments
|
| Janssen Pharmaceuticals | Xarelto | $332 | 19 payments
|
| Medtronic Vascular | Claria Mri | $313 | 12 payments
|
| Novartis Pharmaceuticals | Entresto | $278 | 25 payments
|
| Amgen | Repatha | $75 | 4 payments
|
| Pfizer | Vyndaqel | $59 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $50 | 3 payments
|
| Sanofi-Aventis U.S. | Praluent | $39 | 2 payments
|
| Regeneron Healthcare Solutions | Praluent | $19 | 1 payment
|
| Philips Electronics North America | Trilogy 100 | $15 | 1 payment
|
Professional record
- NPI
- 1962616888
- Licence
- CA A
- Trained
- Wayne State University School of Medicine, 2005 · 21 years ago
- Group
- Torrance Memorial Medical Center · Cor Healthcare Medical Associates · Southern California Hospitalist Network Medical Group Inc · Torrance Health Association Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X)
- Mailing address
- 1360 W 6th St, Suite 200, San Pedro, CA, 90732
- NPI first listed
- 2007-05-09
- NPI last updated
- 2015-01-27
This is when the NPI record was last certified, not a medical board exam.